Program News
News and stories about members of the UNC Lineberger Immunology Research Program
-
UNC researchers present at American Association for Cancer Research’s 115th Annual Meeting
Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.
-
Newly engineered molecule bypasses toxicity previously found in key cancer-fighting pathway
UNC Lineberger researchers have developed a molecule that is much more effective than a previously identified molecule at activating a biological pathway and spurring a strong anti-cancer immune response in preclinical studies.
-
Curated cancer care
UNC Lineberger researchers are using CAR-T to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.
-
Cancer center researchers to present latest findings at international breast cancer meeting
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
-
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
-
Treatment-resistant infections, a “slow-moving catastrophe”
David van Duin, MD, PhD, and colleagues at UNC-Chapel Hill are working to understand and mitigate the global rise of untreatable infections.
-
Thomas C. Shea Clinical Cancer Symposium brings together national leaders in blood cancers
The inaugural symposium featured talks on adoptive cellular therapy for lymphoid malignancies and novel approaches for the treatment of acute myeloid leukemia, myelodysplastic syndromes and myeloproliferative neoplasms.
-
Rooted: Ilona Jaspers
UNC Lineberger member Ilona Jaspers, MS, PhD, has been contributing to research at Carolina for 26 years.
-
Gut microbiome can increase risk, severity of HIV, EBV disease
UNC researchers report that the gut microbiome has a significant impact on the acquisition of Epstein-Barr virus and human immunodeficiency virus-1 infection and plays a role in the course of disease.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
NCI awards Earp, Pylayeva-Gupta five-year, $2.69 million pancreatic cancer research grant
The NCI has awarded has awarded Shelley Earp, MD, and Yuliya Pylayeva-Gupta, PhD, a research project grant to investigate approaches to overcome barriers to pancreatic cancer immunotherapies.
-
Why don’t T cells destroy solid tumors during immunotherapy?
Jessica Thaxton, PhD, MsCR, and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop more potent cancer immunotherapies.
-
UNC Lineberger and UNC researchers discuss latest research at American Society of Hematology Annual Meeting
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
-
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
-
Pylayeva-Gupta awarded Hettleman Prize
UNC named UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, one of four recipients of the Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement.